BOULDER, Colo., Oct. 29 /PRNewswire/ -- Array BioPharma Inc.
(Nasdaq: ARRY) will report financial results for the first quarter of fiscal
2002 on Monday, November 5, 2001, at 4:30 p.m. eastern time and hold a
conference call on Tuesday, November 6, 2001, at 9:00 a.m. eastern time.
Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief
Financial Officer, will lead the call.
CONFERENCE CALL INFORMATION
Date: Tuesday, November 6, 2001
| Time: |
9:00 a.m. eastern time |
Toll-Free: (800) 500-0177
Toll: (719) 457-2679
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be
accessed by dialing toll-free (888) 203-1112, and outside the US
(719) 457-0820. The access code is 636928. Replay of the call will also be
available as a web cast on Array's web site at www.arraybiopharma.com.
Array BioPharma is a drug discovery company creating new drugs through the
integration of chemistry, structural biology and chemoinformatics. We
collaborate with leading pharmaceutical and biotechnology companies to
identify novel small molecule drugs and are leveraging our discovery platform
to develop our own pipeline of proprietary drug candidates. The Array
scientific team has a proven track record of success in identifying promising
drug candidates.
For more information on Array BioPharma, please visit the company's web
site at www.arraybiopharma.com, or contact Tricia Haugeto of Array BioPharma
Inc., (303) 386-1193, thaugeto@arraybiopharma.com.
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,
thaugeto@arraybiopharma.com/
